# Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin

> **NCT00002559** · PHASE1,PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 43 (estimated)

## Conditions studied

- Ovarian Cancer
- Testicular Germ Cell Tumor

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cisplatin
- **DRUG:** ifosfamide
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00002559
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-01
- **Primary completion:** 2003-01
- **Final completion:** 2003-01
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2013-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002559, "Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*